Setting up a standalone innovation lab has become a standard move for large organizations that want to signal strategic seriousness. The labs get distinct branding, separate office space, and budgets that would fund several meaningful product improvements in the core business.
The structural problem with separation
Isolating innovation from operations assumes the two can be meaningfully divided. They cannot. The best product improvements in most industries come from people close to customer complaints, operational constraints, and distribution realities — not from a team insulated from all three.
Where labs occasionally work
When an organization needs to explore a genuinely adjacent technology category without disrupting current revenue streams, separation has merit. Pharmaceutical companies running early-stage research units separate from commercial operations is one legitimate application. The key distinction is that the exploration has a defined handoff point back to the core business.
Where labs consistently underperform
Labs staffed with people selected for being different from the core organization tend to produce ideas the core organization cannot operationalize. The cultural distance that was supposed to enable creativity becomes the reason nothing gets implemented.
After two to three years, most corporate labs produce a portfolio of prototypes, a handful of patents, and a growing question about what exactly the investment produced.
Embedding innovation capacity into existing teams, with dedicated time and clear mandates, tends to produce more usable output at a fraction of the cost.